Please enable JavaScript to continue using this application.

Compare $ACET vs $SER | Chartloom

Compare

$ACET vs $SER

Adicet Bio Inc · Serina Therapeutics Inc

ACET

Adicet Bio Inc

SER

Serina Therapeutics Inc

Compare $ACET vs $SER

Comparing Adicet Bio Inc and Serina Therapeutics Inc

ACETAdicet Bio Inc

SERSerina Therapeutics Inc

ACETAdicet Bio Inc

Market cap

$52M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.4%

52W performance

-62.2%

FCF yield

-162.0%

SERSerina Therapeutics Inc

Market cap

$30M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-64.5%

FCF yield

-70.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACET

SER

Detailed metrics comparison

ACET

Adicet Bio Inc

SER

Serina Therapeutics Inc

Market Cap

ACET$52M

SER$30M

Enterprise Value

ACET$20M

SER$10M

Price

ACET$5.61

SER$2.00

P/E Ratio

ACETN/A

SERN/A

P/S Ratio

ACET1.57x

SER345.73x

EV/Sales

ACET0.74x

SER207.28x

EV/EBITDA

ACET0.00x

SER0.00x

P/B Ratio

ACET0.51x

SER2.66x

P/FCF Ratio

ACETN/A

SERN/A

EV/FCF

ACET-0.24x

SER-0.47x

PEG Ratio

ACETN/A

SERN/A

Forward P/E (NTM)

ACETN/A

SERN/A

Forward P/S (NTM)

ACETN/A

SERN/A

Revenue (TTM)

ACET$0

SER$0

Revenue Growth (YoY)

ACETN/A

SERN/A

Forward Rev Growth

ACET171.3%

SER0.0%

Gross Margin (TTM)

ACET0.0%

SER65.1%

Operating Margin (TTM)

ACET0.0%

SER0.0%

EBITDA Margin (TTM)

ACET0.0%

SER0.0%

Net Margin (TTM)

ACET0.0%

SER0.0%

FCF Margin (TTM)

ACETN/A

SERN/A

Net Income (TTM)

ACET$-99M

SER$-17M

FCF (TTM)

ACET$-85M

SER$-21M

EPS (TTM)

ACET-$9.21

SER-$1.03

ROE (TTM)

ACET-7490.0%

SER-10679.0%

ROA (TTM)

ACET-6087.0%

SER-9480.0%

ROIC (TTM)

ACET-7437.0%

SER-8268.0%

Cash

ACET$33M

SER$23M

Debt

ACET$798K

SER$3M

Net Cash/Debt

ACET$32M

SER$20M

Current Ratio (TTM)

ACET6.71x

SER6.65x

Quick Ratio (TTM)

ACET6.59x

SER6.12x

Debt/Equity (TTM)

ACET0.01x

SER0.16x

Debt/Assets (TTM)

ACET0.0%

SER0.0%

Interest Coverage (TTM)

ACETN/A

SERN/A

Net Debt/EBITDA (TTM)

ACET0.00x

SER0.00x

Beta

ACET1.68

SER8.13

52W Performance

ACET-62.2%

SER-64.5%

YTD Performance

ACET-36.4%

SER-3.8%

% from 52W High

ACET-67.8%

SER-65.0%

% from 52W Low

ACET1.1%

SER63.9%

Asset Turnover (TTM)

ACET0.13x

SER0.02x

FCF Yield (TTM)

ACET-162.0%

SER-70.7%

Earnings Yield (TTM)

ACET-188.7%

SER-56.2%

Dividend Yield (TTM)

ACETN/A

SERN/A

Rule of 40

ACET0.0

SER0.0

EV/GP/RG

ACETN/A

SERN/A

Ticker research

View ACET research View SER research

Metric	ACET Adicet Bio Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$52M	$30M
Enterprise Value	$20M	$10M
Price	$5.61	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	1.57x	345.73x
EV/Sales	0.74x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	171.3%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-17M
FCF (TTM)	$-85M	$-21M
EPS (TTM)	-$9.21	-$1.03
ROE (TTM)	-7490.0%	-10679.0%
ROA (TTM)	-6087.0%	-9480.0%
ROIC (TTM)	-7437.0%	-8268.0%
Financial Health
Cash	$33M	$23M
Debt	$798K	$3M
Net Cash/Debt	$32M	$20M
Current Ratio (TTM)	6.71x	6.65x
Quick Ratio (TTM)	6.59x	6.12x
Debt/Equity (TTM)	0.01x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	8.13
52W Performance	-62.2%	-64.5%
YTD Performance	-36.4%	-3.8%
% from 52W High	-67.8%	-65.0%
% from 52W Low	1.1%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.02x
FCF Yield (TTM)	-162.0%	-70.7%
Earnings Yield (TTM)	-188.7%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACET research	View SER research

Valuation

P/S Ratio

ACET

1.57x

SER

345.73x

EV/FCF

SER

-0.47x

ACET

-0.24x

Growth & revenue

Forward Revenue Growth

ACET

171.3%

SER

0.0%

Profitability & performance

Gross Margin

SER

65.1%

ACET

0.0%

ROE

ACET

-7490.0%

SER

-10679.0%

FCF Yield %

SER

-70.7%

ACET

-162.0%

52-Week Performance

ACET

-62.2%

SER

-64.5%

Detailed metrics comparison

ACET

Adicet Bio Inc

SER

Serina Therapeutics Inc

Market Cap

ACET$52M

SER$30M

Enterprise Value

ACET$20M

SER$10M

Price

ACET$5.61

SER$2.00

P/E Ratio

ACETN/A

SERN/A

P/S Ratio

ACET1.57x

SER345.73x

EV/Sales

ACET0.74x

SER207.28x

EV/EBITDA

ACET0.00x

SER0.00x

P/B Ratio

ACET0.51x

SER2.66x

P/FCF Ratio

ACETN/A

SERN/A

EV/FCF

ACET-0.24x

SER-0.47x

PEG Ratio

ACETN/A

SERN/A

Forward P/E (NTM)

ACETN/A

SERN/A

Forward P/S (NTM)

ACETN/A

SERN/A

Revenue (TTM)

ACET$0

SER$0

Revenue Growth (YoY)

ACETN/A

SERN/A

Forward Rev Growth

ACET171.3%

SER0.0%

Gross Margin (TTM)

ACET0.0%

SER65.1%

Operating Margin (TTM)

ACET0.0%

SER0.0%

EBITDA Margin (TTM)

ACET0.0%

SER0.0%

Net Margin (TTM)

ACET0.0%

SER0.0%

FCF Margin (TTM)

ACETN/A

SERN/A

Net Income (TTM)

ACET$-99M

SER$-17M

FCF (TTM)

ACET$-85M

SER$-21M

EPS (TTM)

ACET-$9.21

SER-$1.03

ROE (TTM)

ACET-7490.0%

SER-10679.0%

ROA (TTM)

ACET-6087.0%

SER-9480.0%

ROIC (TTM)

ACET-7437.0%

SER-8268.0%

Cash

ACET$33M

SER$23M

Debt

ACET$798K

SER$3M

Net Cash/Debt

ACET$32M

SER$20M

Current Ratio (TTM)

ACET6.71x

SER6.65x

Quick Ratio (TTM)

ACET6.59x

SER6.12x

Debt/Equity (TTM)

ACET0.01x

SER0.16x

Debt/Assets (TTM)

ACET0.0%

SER0.0%

Interest Coverage (TTM)

ACETN/A

SERN/A

Net Debt/EBITDA (TTM)

ACET0.00x

SER0.00x

Beta

ACET1.68

SER8.13

52W Performance

ACET-62.2%

SER-64.5%

YTD Performance

ACET-36.4%

SER-3.8%

% from 52W High

ACET-67.8%

SER-65.0%

% from 52W Low

ACET1.1%

SER63.9%

Asset Turnover (TTM)

ACET0.13x

SER0.02x

FCF Yield (TTM)

ACET-162.0%

SER-70.7%

Earnings Yield (TTM)

ACET-188.7%

SER-56.2%

Dividend Yield (TTM)

ACETN/A

SERN/A

Rule of 40

ACET0.0

SER0.0

EV/GP/RG

ACETN/A

SERN/A

Ticker research

View ACET research View SER research

Metric	ACET Adicet Bio Inc	SER Serina Therapeutics Inc
Market & Valuation
Market Cap	$52M	$30M
Enterprise Value	$20M	$10M
Price	$5.61	$2.00
P/E Ratio	N/A	N/A
P/S Ratio	1.57x	345.73x
EV/Sales	0.74x	207.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	2.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-0.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	171.3%	0.0%
Profitability
Gross Margin (TTM)	0.0%	65.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-17M
FCF (TTM)	$-85M	$-21M
EPS (TTM)	-$9.21	-$1.03
ROE (TTM)	-7490.0%	-10679.0%
ROA (TTM)	-6087.0%	-9480.0%
ROIC (TTM)	-7437.0%	-8268.0%
Financial Health
Cash	$33M	$23M
Debt	$798K	$3M
Net Cash/Debt	$32M	$20M
Current Ratio (TTM)	6.71x	6.65x
Quick Ratio (TTM)	6.59x	6.12x
Debt/Equity (TTM)	0.01x	0.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	8.13
52W Performance	-62.2%	-64.5%
YTD Performance	-36.4%	-3.8%
% from 52W High	-67.8%	-65.0%
% from 52W Low	1.1%	63.9%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.02x
FCF Yield (TTM)	-162.0%	-70.7%
Earnings Yield (TTM)	-188.7%	-56.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACET research	View SER research